Trial Site Detail
Drug: |
BIIB022 |
|||
|---|---|---|---|---|
Trial: |
Phase 1 Study of BIIB022 (Anti-IGF-1R Monoclonal Antibody) in Relapsed/Refractory Solid Tumors |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Ongoing, but not recruiting |
|||
Fox Chase Cancer Center333 Cottman Ave |
Principal Investigator: |
Roger Cohen, MD |
|---|---|
Contact: |
Kathleen Lear, RN, OCN, CCRP Phone: 215-214-1511 Email: kathleen.lear@fccc.edu |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Fox Chase Cancer Center Website: |
https://www.protonet.fccc.edu/fccc/pims/ |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.